Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced
GlobeNewswireApr 16 07:00 ET
Investors Give AxoGen, Inc. (NASDAQ:AXGN) Shares A 28% Hiding
The AxoGen, Inc. (NASDAQ:AXGN) share price has softened a substantial 28% over the previous 30 days, handing back much of the gains the stock has made lately.
Simply Wall StMar 17 08:51 ET
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN)
Yahoo FinanceMar 8 23:55 ET
AxoGen(AXGN.US) Officer Sells US$319.89K in Common Stocks
$AxoGen(AXGN.US)$ Officer Donovan Michael Patrick sold 36,310 shares of Common Stocks on Mar 7, 2024 at an average price of $8.81 for a total value of $319.89K.Source: Announcement What is statement o
moomoo NewsMar 8 18:15 ET
AxoGen(AXGN.US) Director Sells US$225K in Common Stocks
$AxoGen(AXGN.US)$ Director Freitag Gregory Gene sold 25,000 shares of Common Stocks on Mar 7, 2024 at an average price of $9 for a total value of $225K.Source: Announcement What is statement of change
moomoo NewsMar 8 18:15 ET
Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing
Michael Patrick Donovan, Vice President, Operations, on March 07, 2024, sold 36,310 shares in Axogen (AXGN) for $319,891. Following the Form 4 filing with the SEC, Donovan has control over a total of
MT NewswiresMar 8 17:43 ET
US$13.80 - That's What Analysts Think AxoGen, Inc. (NASDAQ:AXGN) Is Worth After These Results
Yahoo FinanceMar 8 05:37 ET
New Accounting & Financial Operations Risk for AxoGen – What's the Latest?
TipRanksMar 7 01:01 ET
Axogen's Strong Growth Prospects and Positive Analyst Outlook Prompt Buy Rating and Increased Price Target
TipRanksMar 6 23:17 ET
AxoGen Files $100 Million Mixed-Securities Shelf
AxoGen (AXGN) filed a mixed-securities shelf registration with the US Securities and Exchange Commission covering the potential sale of up to $100 million of common and preferred stock, debt securitie
MT NewswiresMar 6 12:31 ET
AxoGen, Inc. (NASDAQ:AXGN) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 6 08:20 ET
Institutional Investors May Overlook AxoGen, Inc.'s (NASDAQ:AXGN) Recent US$72m Market Cap Drop as Long-term Gains Remain Positive
Key Insights Significantly high institutional ownership implies AxoGen's stock price is sensitive to their trading actions The top 10 shareholders own 50% of the company Insiders have sold recent
Simply Wall StMar 6 06:26 ET
Buy Rating Affirmed: AxoGen's Robust Growth and Market Potential Drive Positive Outlook
TipRanksMar 6 00:35 ET
Q4 2023 AxoGen Inc Earnings Call
Yahoo FinanceMar 5 21:27 ET
AxoGen Releases Updated Corporate Presentation Online
TipRanksMar 5 16:43 ET
Express News | Axogen Shares Are Trading Lower. The Company Reported Q4 Financial Results
Moomoo 24/7Mar 5 12:23 ET
Correct: Axogen 4Q Rev $42.9M, Not $159M
Correct: Axogen 4Q Rev $42.9M, Not $159M
Dow JonesMar 5 11:37 ET
Axogen Shares Fall 13% on Lukewarm 2024 Outlook
By Emon Reiser Shares of Axogen traded lower after the company guided for revenue growth that is cooler than expected for fiscal 2024. The stock fell 13% to $9.17 on Tuesday. Shares remain up 34% ye
WSJMar 5 11:37 ET
Earnings Call Summary | AxoGen(AXGN.US) Q4 2023 Earnings Conference
The following is a summary of the AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript:Financial Performance:AxoGen reported a full year 2023 revenue of $159 million, up 14.7% from the previous year a
moomoo AIMar 5 11:15 ET · Conference Call
Axogen Expects 2024 Revenue Of $177M-$181M, Up 11%-14%, Versus Consensus Of $179.22M, With Gross Margin Of 76%-79%
Axogen Expects 2024 Revenue Of $177M-$181M, Up 11%-14%, Versus Consensus Of $179.22M, With Gross Margin Of 76%-79%
BenzingaMar 5 07:12 ET
No Data
No Data